Neil McNaughton

27PUBLICATIONS
19CO-AUTHORS
PsychophysiologyPersonality and individual differencesNeurology and neuromuscular diseasesClinical psychologyPsychopharmacology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jul 16, 2026
A four-factor model of psychopathy assessed via neural reinforcement sensitivity theory.

|Jul 06, 2026
Ketamine effects on EEG and their links to therapy differ across treatment-resistant major depression, post-traumatic stress disorder, and obsessive-compulsive disorder.

|Mar 09, 2026
Hope for Neurotic Disorders: A Summary of New Zealand Research on the Development of Biomarkers and Novel Treatments.

Neil McNaughton, Shabah M Shadli, B Beaglehole

|Jun 05, 2025
Six weeks open-label oral ketamine for patients with treatment-resistant depression, post-traumatic stress disorder, or obsessive-compulsive disorder.

Ben Beaglehole, Paul Glue, Shona Neehoff

|Dec 21, 2024
Linking Anxiolytic Action to Hippocampal "Theta"-A Personal History.

N McNaughton

|Nov 28, 2024
Ketamine for treatment-resistant obsessive-compulsive disorder: Double-blind active-controlled crossover study.

Ben Beaglehole, Paul Glue, Shona Neehoff

Pageof 5

Frequent Collaborators

6 joint publications

Shabah M Shadli

6 joint publications

Paul Glue

4 joint publications

Calvin K Young

4 joint publications

Ben Beaglehole